Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person

CDC25A protein, a phosphatase required for progression fr...

Class:IdSummation:212961
_displayName

CDC25A protein, a phosphatase required for progression fr...

_timestamp2025-04-05 17:17:10
created[InstanceEdit:212958] Matthews, L, 2008-02-15 23:39:43
literatureReference[LiteratureReference:212978] Cdc25A stability is controlled by the ubiquitin-proteasome pathway during cell cycle progression and terminal differentiation
[LiteratureReference:69264] Rapid destruction of human Cdc25A in response to DNA damage.
[LiteratureReference:9941771] Human Cdc25 A inactivation in response to S phase inhibition and its role in preventing premature mitosis
[LiteratureReference:9941784] The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis
[LiteratureReference:9941775] Degradation of Cdc25A by beta-TrCP during S phase and in response to DNA damage
[LiteratureReference:9941822] SCFbeta-TRCP links Chk1 signaling to degradation of the Cdc25A protein phosphatase
[LiteratureReference:9942580] Regulation of human Cdc25A stability by Serine 75 phosphorylation is not sufficient to activate a S phase checkpoint
[LiteratureReference:9943677] GSK-3 beta targets Cdc25A for ubiquitin-mediated proteolysis, and GSK-3 beta inactivation correlates with Cdc25A overproduction in human cancers
[LiteratureReference:9943993] Mammalian G1- and S-phase checkpoints in response to DNA damage
[LiteratureReference:9943654] NEK11 regulates CDC25A degradation and the IR-induced G2/M checkpoint
[LiteratureReference:9943731] Casein kinase 1 functions as both penultimate and ultimate kinase in regulating Cdc25A destruction
[LiteratureReference:9943730] CK1ε targets Cdc25A for ubiquitin-mediated proteolysis under normal conditions and in response to checkpoint activation
[LiteratureReference:9944016] Ubiquitin ligases and cell cycle control
modified[InstanceEdit:1458614] D'Eustachio, P, 2011-07-21
[InstanceEdit:9941616] Orlic-Milacic, Marija, 2025-03-10
[InstanceEdit:9941780] Orlic-Milacic, Marija, 2025-03-10
[InstanceEdit:9943682] Orlic-Milacic, Marija, 2025-03-31
[InstanceEdit:9944022] Orlic-Milacic, Marija, 2025-04-02
[InstanceEdit:9944339] Orlic-Milacic, Marija, 2025-04-04
[InstanceEdit:9944376] Orlic-Milacic, Marija, 2025-04-04
[InstanceEdit:9944379] Orlic-Milacic, Marija, 2025-04-04
[InstanceEdit:9944603] Orlic-Milacic, Marija, 2025-04-05
text

CDC25A protein, a phosphatase required for progression from G1 to S phase of the cell cycle, is degraded by the ubiquitin-proteasome machinery in both terminally differentiating and cycling cells (Bernardi et al. 2000).

In response to UV light or ionizing radiation (IR), CDC25A in human cells undergoes a rapid ubiquitin- and proteasome-dependent degradation that depends on CHEK1 but not TP53, inducing G1/S arrest that can be bypassed by overexpression of CDC25A (Mailand et al. 2000, reviewed in Teixera and Reed 2013). CHEK2 (Chk2) contributes to CDC25A destruction in response to IR (Falck et al. 2000, reviewed in Bartek and Lukas 2001). For details, please refer to events "Phosphorylation of CDC25A by CHEK1", "Phosphorylation of CDC25A by CHEK2", and "CHEK1 phosphorylates CHEK2-phosphorylated CDC25A". Treatment with hydroxyurea, which induces DNA replication stress and can indirectly lead to DNA damage, leads to a marked decrease in CDC25A protein levels in many human cell lines in a ubiquitin- and proteasome-dependent manner and persistent phosphorylation of CDK2 on tyrosine residue Y15 (Molinari et al. 2000). Besides CHEK1 and CHEK2, other kinases that may contribute to phosphorylation of CDC25A that targets it for ubiquitin-mediated degradation in response to DNA damage or replicative stress are PLK3 and GSK3B (Kang et al. 2008). Osmotic stress can also lead to p38 MAPK phosphorylation-dependent ubiquitination and degradation of CDC25A (Goloudina et al. 2003). Phosphorylation of CDC25A by CHEK1 and likely p38 MAPK and GSK3B primes it for additional phosphorylation by kinases such as NEK11 (Melixetian et al. 2009) or Casein kinases I (Honaker and Piwnica-Worms 2010, Piao et al. 2011), which creates a phosphodegron needed for binding to the SCF-BTrCP E3 ubiquitin ligase complex, leading to ubiquitin-mediated degradation of CDC25A (Busino et al. 2003, Jin et al. 2003, reviewed in Teixeira and Reed 2013).

(summation)[Pathway:69601] Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A [Homo sapiens]
[Change default viewing format]
No pathways have been reviewed or authored by

CDC25A protein, a phosphatase required for progression fr... (212961)